Published • loading... • Updated
Healthy Returns: Employers Aren't Expanding Coverage of GLP-1 Obesity Drugs — Many Are Finding Ways Around It
Summary by CNBC
1 Articles
1 Articles
Healthy Returns: Employers aren't expanding coverage of GLP-1 obesity drugs — many are finding ways around it
About 36% of employers said they provide coverage of GLP-1s for both diabetes and weight loss, the same percentage as 2025 and up from 34% in 2024, the survey said.
·Englewood Cliffs, United States
Read Full ArticleCoverage Details
Total News Sources1
Leaning Left1Leaning Right0Center0Last UpdatedBias Distribution100% Left
Bias Distribution
- 100% of the sources lean Left
100% Left
L 100%
Factuality
To view factuality data please Upgrade to Premium
